Dossier
Generics
Coverage of Generics in the Nexus archive.
- India Fat-Loss Drug Sales Slow After Early Spike From Generics
Sales of fat-loss drugs in India have slowed after an initial surge driven by generic versions of semaglutide-based medications. Semaglutide is the active ingredient in Novo Nordisk’s Ozempic and Wegovy.
- SBP Group Eyes Innovation as It Shifts Beyond Generics
SBP Group is focusing on innovation as it moves away from generics. The company aims to shift its business strategy toward new developments.